UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                            Washington, D. C. 20549

                                   FORM 10-QSB

__X__ Quarterly Report Under Section 13 or 15(d) of The Securities  Exchange Act
of 1934 for the quarterly period ended: March 31, 2007.

____  Transition  Report  Under  Section 13 or 15(d) of the Exchange Act for the
transition period from ____ to ____

                         Commission file number: 0-24930

                               CTD HOLDINGS, INC.
        (Exact name of small business issuer as specified in its charter)

            Florida                                    59-3029743
  (State or other jurisdiction                      (IRS Employer
of incorporation or organization)                  Identification No.)

 27317 N.W. 78th Avenue, High Springs, Florida            32643
 (Address of principal executive offices)              (Zip Code)

          Issuer's telephone number, including area code: 386-454-0887

Former  name,  former  address and former  fiscal  year,  if changed  since last
report: N/A.

Check  whether the issuer (1) filed all reports  required to be filed by Section
13 or 15(d) of the  Exchange  Act during the past 12 months (or for such shorter
period that the registrant was required to file such reports),  and (2) has been
subject to such filing requirements for the past 90 days. (x)Yes (_) No

Indicate by check mark whether the  registrant is a shell company (as defined in
Rule 12b-2 of the Exchange Act) (_)Yes (x)No

As of May 10, 2007, the Company had outstanding  15,918,489 shares of its common
stock.

Transitional Small Business Disclosure Format: (_)Yes (x)No


<PAGE>

PART I.  Financial Information

Item 1.  Financial Statements.


                              CTD HOLDINGS, INC.
                           CONSOLIDATED BALANCE SHEET
                                   (Unaudited)


                                     ASSETS

                                                                March 31, 2007
                                                                --------------
CURRENT ASSETS
 Cash and cash equivalents                                        $    39,229
 Accounts receivable                                                   62,306
 Inventory                                                             93,573
 Investment due from related party                                    141,989
 Prepaid and other current assets                                      20,779
                                                                  -----------
     Total current assets                                             357,876


PROPERTY AND EQUIPMENT, NET                                           413,636

OTHER
 Intangibles, net                                                       9,918
                                                                  -----------
  TOTAL ASSETS                                                    $   781,430
                                                                  ===========


                                   (Continued)

                                       F-2


<PAGE>



                                CTD HOLDINGS, INC.
                           CONSOLIDATED BALANCE SHEET
                                   (Unaudited)



                      LIABILITIES AND STOCKHOLDERS' EQUITY

                                                                 March 31, 2007
                                                                 --------------
CURRENT LIABILITIES
 Accounts payable and accrued expenses                            $    44,299
 Shareholder Loan                                                       1,599
 Current portion of long-term debt                                      6,182
                                                                  -----------
         Total current liabilities                                     52,080
                                                                  -----------

LONG-TERM LIABILITIES
 Long-term debt, less current portion                                 140,873
                                                                  -----------

STOCKHOLDERS' EQUITY
 Class A  common  stock,  par  value  $  .0001  per  share,
  100,000,000  shares authorized, 16,450,333 shares
  issued and outstanding                                                1,645
 Preferred stock, par value $.0001 per share, 5,000,000
  shares authorized; Series A, 1 share issued and outstanding               -
 Additional paid-in capital                                         2,906,240
 Accumulated deficit                                               (2,319,408)
                                                                  -----------
      Total stockholders' equity                                      588,477
                                                                  -----------
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY                        $   781,430
                                                                  ===========


                See Accompanying Notes to Financial Statements.

                                       F-3


<PAGE>



                               CTD HOLDINGS, INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS

                                   (Unaudited)



                                                        Three Months Ended
                                                             March 31,
                                                  -----------------------------
                                                      2007             2006
                                                  ------------     ------------
PRODUCT SALES                                     $    151,226     $    166,810

COST OF PRODUCTS SOLD                                    2,145           40,217
                                                  ------------     ------------
GROSS PROFIT                                           149,081          126,593
                                                  ------------     ------------
SELLING, GENERAL AND ADMINISTRATIVE EXPENSES           150,931           98,666
ACQUISITION COSTS                                            -           49,662
                                                  ------------     ------------
                                                       150,931          148,328
                                                  ------------     ------------
OTHER INCOME (EXPENSE)
 Investment and other income                             6,942            3,582
 Interest expense                                       (1,779)          (1,892)
                                                  ------------     ------------
     Total other income                                  5,163            1,690
                                                  ------------     ------------
NET INCOME (LOSS) BEFORE INCOME TAXES                    3,313          (20,045)

INCOME TAXES                                                 -                -
                                                  ------------     ------------
NET INCOME (LOSS)                                        3,313          (20,045)
                                                  ============     ============
NET INCOME (LOSS) PER COMMON SHARE                        .000            (.001)
                                                  ============     ============

WEIGHTED AVERAGE NUMBER OF COMMON
 SHARES OUTSTANDING                                 16,077,937       14,072,286
                                                  ============     ============


                See Accompanying Notes to Financial Statements.

                                       F-4


<PAGE>



                                CTD HOLDINGS, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
               Increase (Decrease) in Cash and Cash Equivalents
                                   (Unaudited)



                                                         Three Months Ended
                                                              March 31,
                                                     --------------------------
                                                         2007            2006
                                                     ------------  ------------
CASH FLOWS FROM OPERATING ACTIVITIES
 Net income (loss)                                   $      3,313  $    (20,045)
                                                     ------------  ------------
 Adjustments  to reconcile  net income  (loss)
  to net cash provided by operating activities:

   Depreciation and amortization                            5,232         6,580
   Stock issued to employees                               25,052        21,745
   Increase or decrease in:
     Accounts receivable                                   (3,197)      (28,372)
     Inventory                                            (13,826)      (42,926)
     Prepaid expenses                                       3,334             -
     Accounts payable and accrued expenses                 (7,867)       84,544
                                                     ------------  ------------
       Total adjustments                                    8,728        41,571
                                                     ------------  ------------
    NET CASH PROVIDED BY OPERATING
     ACTIVITIES                                            12,041        21,526
                                                     ------------  ------------

CASH FLOWS FROM INVESTING ACTIVITIES
 Purchase of equipment and building improvements           (6,976)       (2,326)
 Investment with related party                             (6,449)     (122,172)
 Redemption of certificate of deposit                           -       121,028
                                                     ------------  ------------
  NET CASH USED FOR INVESTING ACTIVITES                   (13,425)       (3,470)
                                                     ------------  ------------


CASH FLOWS FROM FINANCING ACTIVITIES
 Payment on notes payable                                  (1,129)       (1,812)
 Payment received (paid) on stockholder loan               18,113        (3,467)
 Loan to shareholder                                            -        (6,912)
                                                     ------------  ------------
    NET CASH PROVIDED BY (USED FOR)
     FINANCING ACTIVITIES                                  16,984       (12,191)
                                                     ------------  ------------
NET INCREASE IN CASH AND CASH EQUIVALENTS                  15,600         5,865

CASH AND CASH EQUIVALENTS, beginning of period             23,629        31,026
                                                     ------------  ------------
CASH AND CASH EQUIVALENTS, end of period             $     39,229  $     36,891
                                                     ============  ============

                                   (Continued)

                                       F-5
<PAGE>

                                CTD HOLDINGS, INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
               Increase (Decrease) in Cash and Cash Equivalents
                                   (Unaudited)
                                   (Concluded)



                                                         Three Months Ended
                                                              March 31,
                                                     --------------------------
                                                         2007          2006
                                                     ------------  ------------
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Cash paid during the period for interest             $      1,779  $      5,359
                                                     ============  ============

SUPPLEMENTAL DISCLOSURE OF NONCASH INVESTING AND
 FINANCING ACTIVITY
  Common stock issued for services                   $     25,052  $     21,745
                                                     ============  ============



                See Accompanying Notes to Financial Statements.

                                       F-6


<PAGE>



                                CTD HOLDINGS, INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                                 March 31, 2007
                                   (Unaudited)


The information  presented  herein as of March 31, 2007 and for the three months
ended March 31, 2007 and 2006, is unaudited.

(1) BASIS OF PRESENTATION:

The  accompanying  financial  statements  include  CTD  Holdings,  Inc.  and its
subsidiaries.

The  accompanying  financial  statements  have been prepared in accordance  with
generally accepted accounting  principles for interim financial  information and
with the  instructions  to Form  10-QSB  and  Rule  10-01  of  Regulations  S-X.
Accordingly,  they do not include all of the information and footnotes  required
by generally accepted accounting  principles for complete financial  statements.
In the opinion of management,  all adjustments  (consisting of normal  recurring
adjustments) considered necessary for a fair presentation have been included.

Operating  results for the three month  period  ended  March 31,  2007,  are not
necessarily  indicative  of the results that may be expected for the year ending
December 31, 2007. For further  information,  refer to the financial  statements
and footnotes thereto included in the Company's annual report of Form 10-KSB for
the year ended December 31, 2006.

(2) NET INCOME (LOSS) PER COMMON SHARE:

Net  income  (loss)  per  common  share  is  computed  in  accordance  with  the
requirements of Statement of Financial  Accounting Standards No. 128 (SFAS 128).
SFAS 128 requires net income (loss) per share information to be computed using a
simple  weighted  average  of  common  shares  outstanding  during  the  periods
presented.  SFAS 128 eliminated the previous requirement that earnings per share
include the effect of any dilutive common stock equivalents in the calculation.

(3) INCOME TAXES

For 2006,  no income tax  expense or benefit  was  reported  for the three month
period  ended  March 31,  2006 due to the  Company  realizing a tax loss for the
period. The Company increased its deferred tax asset valuation allowance for the
increase in the deferred tax asset as a result of its tax loss.

For 2007,  no income tax expense was  reported  for the three month period ended
March 31, 2007,  due to the Company  utilizing  the benefit of its net operating
loss carryforward.

(4) CONCENTRATIONS

Sales to the three major  customers were 64% of total sales for the three months
ended March 31, 2007. Sales to three major customers were 66% of total sales for
the three months ended March 31, 2006.

Substantially all 2007 and 2006 inventory purchases were from three vendors.

The Company has only one source for certain manufactured inventory. However, the
Company has  manufactured  these products in the past and could do so again,  if
necessary. There are multiple sources for its other inventory products.

                                       F-7
<PAGE>

(5) COMMITMENTS AND CONTINGENCIES

For 2007,  the Company has  employment  agreements  with two  officers for total
monthly  salaries of $5,000.  In addition,  the  Company's  president is awarded
shares of common  stock each month.  The number of shares due is equal to $6,500
divided by eighty  percent of the closing  price of the  Company's  common stock
price on the last day of each month. The Company  recognizes an expense equal to
the fair value of the stock  determined  using the average stock closing trading
price for the month  multiplied by number of shares awarded for that month.  The
stock is subject to trading  restrictions  under Rule 144.  For the three months
ended March 31, 2007,  the Company  awarded  744,792  shares and  recognized  an
expense of $25,052 for stock awarded under the agreements.

For 2006,  the Company has  employment  agreements  with two  officers for total
monthly  salaries of $4,900.  In addition,  the  officers are awarded  shares of
common stock each month.  The number of shares due is equal to $6,000 divided by
eighty  percent of the closing price of the Company's  common stock on that last
day of each month. The Company  recognizes an expense equal to the fair value of
the stock determined using the average stock closing trading price for the month
multiplied by the number of shares awarded for that month.  The stock is subject
to trading  restrictions  under Rule 144.  For the three  months ended March 31,
2006,  the Company  awarded  357,142 shares and recognized an expense of $21,745
for stock awarded under these agreements.

On February 7, 2007,  Registrant  and C.E. Rick  Strattan  filed suit in Circuit
Court in Palm Beach County,  Florida, (Case Number  2007CA001818XXXXMB)  seeking
the return of the Class A Preferred  Share and  damages  from  defendants  Eline
Entertainment  Group,  Inc., Eline Holding Group, Inc., Yucatan Holding Company,
Steven T. Dorrough,  Jayme Dorrough, and Barry Rothman, based on representations
made in connection  with the Share Exchange  Agreement dated August 11, 2005, as
amended and the enforcement of the agreement.

(6)  CHANGE IN ACCOUNTING ESTIMATE

During 2007,  the Company  received a favorable  price  adjustment for inventory
acquired  and resold in 2006,  resulting  in reduction in cost of goods sold for
2007 of $7,700.

<PAGE>

Item 2. Management's Discussion and Analysis or Plan of Operation.

Introduction

CTD Holdings,  Inc.  (referred to as the "Company," "CTD" or in the first person
notations of "we," "us," and "our") began  operations in 1990.  Our revenues are
principally   derived  from  retail  sales  of  cyclodextrins  and  cyclodextrin
complexes.  Our sales are primarily to major  chemical  supply houses around the
world, pharmaceutical companies, and food companies for research and development
and to diagnostics  companies.  We acquire our products principally from outside
the United  States,  largely from Japan and Hungary,  but are gradually  finding
satisfactory  supply  sources  in the United  States  and China.  While we enjoy
better supply prices from outside the United States,  rising  shipping costs are
making domestic sources more competitively priced. To add value to our products,
we maintain a  comprehensive  database of patented  and patent  pending  uses of
cyclodextrins  from the United  States.  We also  maintain a less  comprehensive
database that includes  patents issued in many other countries  including Japan,
Germany and others.  This  information  is available to our  customers.  We also
offer our customers our  knowledge of the  properties  and potential new uses of
cyclodextrins and cyclodextrin complexes.

As most of our customers  use our  cyclodextrin  products in their  research and
development  activities,  their ordering from us is unpredictable with regard to
timing,  product mix and volume.  We also have four major  customers whom have a
significant effect on our revenues when they increase or decrease their research
and development  activities that use cyclodextrins.  We keep in constant contact
with these  customers  as to their  cyclodextrin  needs so we can  maintain  the
proper  inventory  composition and quantity in anticipation of their needs.  The
sales to major  customers  and the product mix and volume of products sold has a
significant effect on our revenues and gross profit. These factors contribute to
our significant revenue volatility from quarter to quarter and year to year.

<PAGE>

In 2004, we amended the Company's Articles of Incorporation authorizing a series
of "blank check"  preferred stock  consisting of 5,000,000 shares and creating a
series of Series A Preferred Stock,  setting forth its designations,  rights and
preferences.  The more significant right is Series A Preferred shareholders vote
with the  holders  of common  stock on all  matters  submitted  to a vote of our
shareholders.  Share of Series A Preferred  Stock are  entitled to one vote more
than one-half of all votes  entitled to be cast by all holders of voting capital
stock of the Company on any matter  submitted to holders of common  shares so as
to  ensure  that the votes  entitled  to be cast by the  holder of the  Series A
Preferred  Stock  are  equal to at least a  majority  of the  total of all votes
entitled  to be cast by the  holders of common  shares.  In 2004,  we issued one
share of Series A Preferred Stock to C.E. Strattan,  our majority shareholder in
exchange for 1,029,412  shares of common stock held by him, which he voluntarily
surrendered to the Company and were cancelled.  Effective  August 11, 2005, C.E.
Strattan  contractually  transferred  the one  outstanding  share  of  Series  A
Preferred Stock to Eline Entertainment  Group, Inc. (Eline).  The agreement with
Eline  provides for advances to the Company of up to an aggregate of  $1,500,000
to acquire  Cyclolab,  at Eline's  sole  discretion.  Eline is an SEC  reporting
company currently not in reporting compliance.  In September 2006, the company's
President, Mr. Strattan,  demanded, in accordance with the expired contract, the
return  of  the  Series  A  Preferred  Stock  in  the  form  of  a  stock  power
authorization since the physical share never left the possession of its original
owner,  Mr.  Strattan.  The demand  letter was sent to the address  given in the
contract and was never  acknowledged  nor responded to by Eline. The Company has
filed a legal  action  with  regard to its  agreement  with  Eline.  See  "Legal
Proceedings".

Liquidity and Capital Resources

Our cash and short-term  investments increased to $181,000 as of March 31, 2007,
compared to $159,000 as of December 31, 2006.  The increase for the three months
ended  March  31,  2007,  was due  primarily  to an  increase  in cash flow from
operations.

As of March 31, 2007, our working  capital was $305,000  compared to $264,000 at
December 31, 2006. Our cash flows from  operations for the first three months of
2007 was $12,000  compared to $22,000 for the same period in 2006. This decrease
was due primarily to timing differences in accounts payable.

We believe our working  capital is sufficient  to run our  operations at current
expected future operating levels into the near future. We do not require capital
in the next twelve months for normal operations.

<PAGE>

Controlling  cash expenses  continues to be  management's  primary  fiscal tool.
However,  growth  requires  increased  expenditures  and  we  feel  that  it  is
appropriate  during the current growth stage to engage consultants that can help
the Company in financial areas outside its expertise,  accepting that these fees
will act to reduce  profitability.  We are working hard to increase  revenues to
balance these new  expenses,  but cannot be sure that such effort will be enough
in the short term to sustain profitable financial performance.

Beginning in 2003, we began improvements and renovations of our corporate office
and have invested  $123,000 through  December 31, 2004.  During 2005 and through
March 31, 2006, we suspended our improvement and renovations program to redirect
our financial resources to the CycloLab  acquisition.  We began more renovations
during the second quarter of 2006 and  capitalized  $17,000 of  improvements  in
2006.  For the three months  ended March 31, 2007,  we  capitalized  $7,000.  We
remain  committed to a Research Park  facility for the 40-acre site.  The office
renovations  will be followed by improved  security  operations and modest guest
facilities.  Contingent on the Company's  ability to financially  support modest
expansions that will lead to a formal site plan, we anticipate spending at least
another  $100,000  over the next two years to position the Company to initiate a
5-year plan for a new Cyclodextrin Research Park.

We have no off-balance sheet arrangements at March 31, 2007.

Results of Operations

Total product  sales to date in 2007 were $151,000  compared to $167,000 for the
same period in 2006. Our major customers  continue to be repeat  purchasers.  In
2007,  three of our major customers  accounted for 64% of our sales. In 2006, we
had three major customers accounting for 66% of our sales.

Our gross  profit  margin  increased to 99% for the three months ended March 31,
2007 from 76% for the three months ended March 31, 2006, compared to 85% for the
year ended  December  31,  2005.  During  2007,  we received a  favorable  price
adjustment  for some  inventory  we acquired  and resold in 2006,  resulting  in
reduction  in our 2007 cost of goods  sold of $7,700,  which had a 5%  favorable
gross profit effect.  Changes in the product mix in sales also has a significant
effect on our overall gross profit percentage form period to period.  During our
attempt to acquire  CycloLab  during  2006,  we were buying most of our products
from CycloLab. This has resulted in termporary increased product costs and lower
gross margins for some products than we have experienced historically.

<PAGE>

Our SG&A  expenses  increased  to $151,000  for the three months ended March 31,
2007, from $148,000 for the three months ended March 31, 2006. During 2007, SG&A
expenses  include a $25,000 bonus to our President and $19,000 in legal expenses
related to the lawsuit with Eline  Entertainment  Group,  Inc.  During 2006,  we
incurred $50,000 in direct expenses related to consulting,  legal and accounting
fees incurred as a result of the Company's attempted acquisition of Cyclolab.

We may incur  significant  future  legal fees as the result of our lawsuit  with
Eline Entertainment Group, Inc.

We recognized net income of $3,000 for the three months March 31, 2007, compared
to a net loss of $(20,000) for the three months ended March 31, 2006.

We will continue to introduce new products that will increase  sales revenue and
implement  a strategy of creating or  acquiring  operational  affiliates  and/or
subsidiaries  that  will use  cyclodextrins  in  herbal  medicines,  waste-water
remediation,  pharmaceuticals,  and foods.  We also  intend to pursue  exclusive
relationships with major cyclodextrin manufacturer(s) and specialty cyclodextrin
labs to distribute their products.  We continue to be the exclusive  distributor
in North America of the cyclodextrin  products manufactured by Cyclolab Research
Laboratories in Budapest, Hungary.

In keeping with its  commitment to use the internet as a major  advertising  and
public relations outlet, the Company intends to apply greater human resources to
the updating  and  maintaining  of its web site.  This  valuable  asset has been
instrumental in creating and  maintaining a worldwide  leadership role for us in
the  implementation  of research and  commercialization  of CD applications.  We
believe the  maintenance  and growth of our web site will return that investment
many times.

<PAGE>

Item 3. Controls and Procedures.

(a) Evaluation of disclosure controls and procedures.

The Company's  management,  recognizes its  responsibility  for establishing and
maintaining  internal  control over financial  reporting for the Company.  After
evaluating the  effectiveness  of our  "disclosure  controls and procedures" (as
defined in the Securities Exchange Act of 1934 Rules 13a-15(e) and 15d-15(e)) as
of March  31,  2006  (the  "Evaluation  Date"),  the  Company's  management  has
concluded,  as of the  Evaluation  Date, the Company's  disclosure  controls and
procedures were adequate and designed to ensure the  information  required to be
disclosed in the reports filed or submitted by us under the Securities  Exchange
Act of  1934  is  recorded,  processed,  summarized  and  reported  with  in the
requisite time periods.  Although the Company's existing disclosure controls and
procedures  are  adequate,  the  Company's  management  acknowledges  a material
weakness may exist in those  controls and  procedures in that i) the  accountant
employed  by the  Company  has no training  regarding  financial  reporting  and
presentation   rules  and   regulations  of  the  SEC;  and  ii)  the  Company's
President/CEO,  who oversees all the accountants' work and provides all internal
control functions, while possessing a MBA from the University of Florida, has no
training in matters of accounting,  financial  reporting,  or presentation rules
and regulations of the SEC.

(b) Effectiveness of Internal Control

The  Company's  management is reviewing  the  Company's  internal  controls over
financial reporting to determine the most suitable recognized control framework.
The  Company  will  give  great  weight  and  deference  to the  product  of the
discussions  of the SEC's Advisory  Committee on Smaller  Public  Companies (the
"Advisory Committee") and the Committee of Sponsoring  Organizations' task force
entitled  Implementing  the COSO Control  Framework in Smaller  Businesses  (the
"Task  Force").  Both the Advisory  Committee and the Task Force are expected to
provide practical, needed guidance regarding the applicability of Section 404 of
the  Sarbanes-Oxley  Act to small  business  issuers.  The Company's  management
intends to perform the evaluation  required by Section 404 of the Sarbanes-Oxley
Act at such time as a framework is adopted by the Company.  For the same reason,
the Company's registered  accounting firm has not issued an "attestation report"
on the Company  management's  assessment  of  internal  controls.  Although  the
Company's  existing  disclosure  controls  and  procedures  are  adequate,   the
Company's  management  acknowledges  a  material  weakness  may  exist  in those
controls and procedures in that i) the accountant employed by the Company has no
training regarding financial reporting and presentation rules and regulations of
the SEC; and ii) the Company's President/CEO,  who oversees all the accountants'
work and provides all internal  control  functions,  while possessing a MBA from
the University of Florida,  has no training in matters of accounting,  financial
reporting, or presentation rules and regulations of the SEC.

<PAGE>

(c) Changes in internal controls.

After  evaluation by the Company's  management,  the  Company's  management  has
determined there were no significant  changes in the Company's internal controls
or in other  factors  that could  significantly  affect the  Company's  internal
controls subsequent to the Evaluation Date.

Part II.  OTHER INFORMATION

Item 1.  Legal Proceedings.

On February 7, 2007,  Registrant  and C.E. Rick  Strattan  filed suit in Circuit
Court in Palm Beach County,  Florida, (Case Number  2007CA001818XXXXMB)  seeking
the return of the Class A Preferred  Share and  damages  from  defendants  Eline
Entertainment  Group,  Inc., Eline Holding Group, Inc., Yucatan Holding Company,
Steven T. Dorrough,  Jayme Dorrough, and Barry Rothman, based on representations
made in connection  with the Share Exchange  Agreement dated August 11, 2005, as
amended and the enforcement of the agreement.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds.

NONE

Item 3. Defaults Upon Senior Securities.

NONE

Item 4.  Submission of Matters to a Vote of Security Holders.

NONE

Item 5.  Other Information.

NONE

<page>

Item 6.  Exhibits.


     (2)  Plan of purchase, sale, reorganization, arrangement,
          liquidation or succession                                       None

     (3)  Articles of incorporation and by-laws

          (i)   Articles of Incorporation filed August 9, 1990               *

          (ii)  By-Laws                                                      *

          (iii) Certificates of Amendment to the Articles of
                Incorporation  filed November 18, 1993 and
                September 24, 1993                                           *

     (4)  Instruments  defining  the  rights  of  security  holders,
          including indentures

          (a)  Specimen Share Certificate for Common Stock.                  *

     (10) Material Contracts

          (10.1) Agreement of Shareholders  dated November 11, 1993
                 by and among C.E. Rick Strattan, Garrison Enterprises,
                 Inc. and the Company.                                       *

          (10.2) Lease Agreement dated July 7, 1994.                        **

          (10.3) Consulting  Agreement  dated July 29, 1994 between
                 the Company and Yellen Associates.                          *

          (10.4) License  Agreement  dated December 20, 1994 between
                 the Company and Herbe Wirkstoffe GmbH.                      *

          (10.5) Joint Venture  Agreement  between the Company and
                 Ocumed,  Inc. dated May 1, 1995,  incorporated  by
                 reference  to the  Company's Form 10-QSB for the
                 quarter ended June 30, 1995.                               **

          (10.6) Extension of Agreement between the Company and
                 Herbe Wirkstoffe GmbH.                                    ***

<PAGE>

          (10.7) Lease Extension                                             +

          (10.8) Loan Agreement with John Lindsay                            +

          (10.9) Small Potatoes Contract                                     +

         (10.10) Employment  Agreement  with C.E.  Rick Strattan
                 dated May 30, 2001                                         ++

         (10.11) Employment  Agreement of C.E. Rick Strattan
                 dated October 14, 2003                                    +++

         (10.12) Employment  Agreement  of George L. Fails
                 dated  October 14, 2003                                  ****

         (10.13) Addendum to Share Exchange Agreement with Eline
                 Entertainment Group                                      ++++

         (10.14) Share Exchange Agreement with Eline Entertainment
                 Groups                                                  +++++

     (11) Statement re: Computation of Per Share Earnings         Note 1(k) to
                                                                     Financial
                                                                    Statements

     (15) Letter on Unaudited Interim Financial Information               ****

     (18) Letter on change in accounting principles                       None

     (19) Reports Furnished to Security Holders                           None

     (22) Published  Report regarding Matters Submitted to Vote of
          Security  Holders                                               None

     (23) Consent of Experts and Counsel                                  None

     (24) Power of Attorney                                               None

<PAGE>

     (31) Rule 13a-14(a)/15d-14a(a) Certifications                        ****

     (32) Section 1350 Certifications                                     ****

     (99) Additional Exhibits                                             None

     (100)XBRL-Related Documents                                          None

*    Incorporated  by  reference  to the  Company's  Form  10-SB  filed with the
     Securities and Exchange Commission on February 1, 1994.

**   Incorporated  by  reference  to the  Company's  Form 10-KSB  filed with the
     Securities and Exchange Commission on March 29, 1997.

***  Incorporated  by  reference  to the  Company's  Form 10-KSB  filed with the
     Securities and Exchange Commission on March 28, 2000.

**** Filed herewith.

+    Incorporated  by  reference  to the  Company's  Form 10-KSB  filed with the
     Securities and Exchange Commission on April 2, 2001.

++   Incorporated  by  reference  to the  Company's  Form 10-KSB  filed with the
     Securities and Exchange Commission on April 1, 2002.

+++  Incorporated by reference to Form S-8 filed December 1, 2003.

++++ Incorporated  by  reference  to the  Company's  Form  8-K  filed  with  the
     Securities and Exchange Commission on September 21, 2005.

+++++Incorporated  by  reference  to the  Company's  Form  8-K  filed  with  the
     Securities and Exchange Commission on August 15, 2005.

<page>

                                   SIGNATURES

In  accordance  with the Exchange Act, the  registrant  caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.

                                             CTD HOLDINGS, INC.



Date:  May 15, 2007                          /s/ C.E. Rick Strattan
                                             -----------------------------
                                             C.E. Rick Strattan, President
                                             Chief Executive Officer,
                                             Chief Operating Officer and
                                             Chief Financial Officer